期刊文献+

肌聚糖病的99Tc^m—MIBI门控心肌灌注断层显像评价

Detection of sarcoglycanopathy with ~ Tcm-MIBI gated myocardial perfusion imaging
原文传递
导出
摘要 目的探讨99Tc^m一MIBIG—MPI评价肌聚糖病患者心肌受损的价值。方法临床、分子病理确诊的肌聚糖病患者8例(男3例,女5例,年龄10—30岁)、对照者4名均接受99TcmMIBIG—MPI。原始数据按常规处理成断层图像,再应用定量门控分析软件(QGS)进行左室功能定量分析。采用将左心室分为7个节段、20个亚段的5分制(0—4分)半定量方法,用于评估心肌受损的程度。结果8例患者99Tcm-MIBIG—MPI阳性7例。7例阳性患者140个心肌亚段中共检出59个亚段异常。按病变累及室壁节段(7个节段)分为:单一室壁节段异常1例,2个室壁节段异常2例,3个及3个以上室壁节段异常、病灶呈散在性分布4例。8例肌聚糖患者中5例患者左心室扩大,其中3例左室射血分数为(43.1±2.8)%。结论99Tcm-MIBIG—MPI能直观探测肌聚糖病患者的心肌损害,可作为肌聚糖病患者心肌损害早期诊断和远期随访的辅助诊断方法。 Objective To investigate the clinical value of 99Tcm-MIBI gated G-MPI in detecting the myocardial damage in sarcoglycanopathy. Methods 99 Tcm _ MIBI G - MPI was performed in 8 patients (3 males, 5 females, age ranged from 10 to 30 y) with sarcoglycanopathy confirmed by clinical results and molecular pathology and 4 healthy persons as control group. Quantitative gated SPECT (QGS) software was used for processing and interpretation. Myocardium of left ventricle was divided into 7 segments and 20 sub- segments. A five-point scoring system was used to evaluate the myocardial damage. Results Seven patients showed positive results in G-MPI (7/8). Fifty-nine sub-segments of injured myocardium were detected in the 140 sub-segments of 7 abnormal patients. One abnormal segment was observed in 1 patient, two abnor- mal segments were detected in 2 patients, and ≥ 3 abnormal segments were observed in 4 patients. Enlarged left ventricles were detected in 5 patients (5/8), and the LVEF of 3 patients among them decreased to (43. 1 ± 2.8) %. Conclusion 99Tcm-MIBI G-MPI can detect myocardial damage in sarcoglycanopathy as a direct and non-invasive method, and can be used in the early diagnosis and long-term follow-up in sarcogly- canopathy.
出处 《中华核医学杂志》 CAS CSCD 北大核心 2011年第5期317-319,共3页 Chinese Journal of Nuclear Medicine
关键词 肌营养不良 心肌 体层摄影术 发射型计算机 单光子 MIBI Muscular dystrophy Myocardium Tomography, emission-computed, single-photon MIBI
  • 相关文献

参考文献7

  • 1Meena AK, Sreenivas D, Sundaram C, et al. Sarcoglycanopathies: a clinico-pathological study. Neurol India, 2007, 55: 117-121.
  • 2李艳梅,李娟.门控心肌灌注显像在经皮冠状动脉介入治疗中的临床价值[J].中华核医学杂志,2010,30(2):125-128. 被引量:4
  • 3Sandona D, Betto R. Sarcoglycanopathies: molecular pathogenesis and therapeutic prospects. Expert Rev Mol Med, 2009, 11 : e28.
  • 4Ozawa E, Noguchi S, Mizuno Y, et al . From dystrophinopathy to sarcoglycanopathy: evolution of a concept of muscular dystrophy. Muscle Nerve, 1998, 21 : 421-438.
  • 5刘秀杰 马寄晓.临床心肺核医学[M].北京:北京医科大学中国协和医科大学联合出版社,1996.233.
  • 6杜艳,杨敏福,何作祥.门控心肌断层显像定量分析左心室功能[J].中华核医学杂志,2008,28(5):354-356. 被引量:3
  • 7Weeler MT, Zamegar S and McNally EM. ζ-Sarcoglycan, a novel component of the sarcoglycan complex, is reduced in muscular dys- trophy. Hum Mol Genet, 2002, 11 : 2147-2154.

二级参考文献36

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部